Outcomes of Over 1000 Heart Transplants Using Hepatitis C–Positive Donors in the Modern Era
- 8 November 2022
- journal article
- conference paper
- Published by Elsevier in The Annals of Thoracic Surgery
- Vol. 115 (2) , 493-500
Abstract
No abstract availableKeywords
Funding Information
- Abbott Laboratories
- United Therapeutics Corporation
This publication has 27 references indexed in Scilit:
- Use of Hepatitis C Positive Organs: Patient Attitudes in Urban ChicagoAmerican Journal of Nephrology, 2018
- Current Use of Hearts From Hepatitis C Viremic DonorsCirculation: Heart Failure, 2018
- Early outcomes using hepatitis C–positive donors for cardiac transplantation in the era of effective direct-acting anti-viral therapiesThe Journal of Heart and Lung Transplantation, 2018
- The Drug Overdose Epidemic and Deceased-Donor Transplantation in the United StatesAnnals of Internal Medicine, 2018
- The American Society of Transplantation Consensus Conference on the Use of Hepatitis C Viremic Donors in Solid Organ TransplantationAmerican Journal of Transplantation, 2017
- Improving Organ Utilization to Help Overcome the Tragedies of the Opioid EpidemicAmerican Journal of Transplantation, 2016
- Decreased post-transplant survival among heart transplant recipients with pre-transplant hepatitis C virus positivityThe Journal of Heart and Lung Transplantation, 2011
- Peginterferon Alfa-2b or Alfa-2a with Ribavirin for Treatment of Hepatitis C InfectionNew England Journal of Medicine, 2009
- Hepatitis C Virus Seropositivity in Organ Donors and Survival in Heart Transplant RecipientsJAMA, 2006
- Donor hepatitis-C seropositivity is an independent risk factor for the development of accelerated coronary vasculopathy and predicts outcome after cardiac transplantationThe Journal of Heart and Lung Transplantation, 2004